A Roadmap to Antibody Drug Discovery
In recent years, therapeutic antibodies have become the predominant class of new drugs developed in order to combat different diseases including cancers and autoimmune diseases among others. Antibody drug discovery does not come without its challenges including screening, characterization and target identification.
Download this infographic to learn more about scalable solutions for each milestone including:
- Target discovery
- Lead generation, identification and optimization
- Preclinical testing
- FDA guidance for the industry
